← SynDRA
RILEMATOVIR
SynDRA canonical compound SYN0039868 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | RSV fusion inhibitor |
All known targets
Mechanisms of action (all sources)
- RSV fusion inhibitor
- Inhibitor
Cross-references
Synonyms
- Jnj-53718678
- JNJ-53718678
- JNJ-678
- UNII-NQ99E8OH3P
- NQ99E8OH3P
- 3-((5-chloro-1-(3-(methylsulfonyl)propyl)-1H-indol-2-yl)methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one
- 3-[[5-Chloranyl-1-(3-Methylsulfonylpropyl)indol-2-Yl]methyl]-1-[2,2,2-Tris(Fluoranyl)ethyl]imidazo[4,5-C]pyridin-2-One
- Rilematovir [INN]
- CHEMBL4437054
- SCHEMBL17529353
- HY-112180
- CS-0043622
- C(CCN1C(=CC2=CC(=CC=C12)Cl)CN1C2=C(N(C1=O)CC(F)(F)F)C=CN=C2)S(=O)(=O)C
- 2H-Imidazo(4,5-C)pyridin-2-one, 3-((5-chloro-1-(3-(methylsulfonyl)propyl)-1H-indol-2-yl)methyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
- 3-((5-Chloro-1-(3-methylsulfonylpropyl)indol-2-yl)methyl)-1-(2,2,2-trifluoroethyl)imidazo(4,5-C)pyridin-2-one
- 6YA
- JNJ 53718678
- jnj53718678
- RefChem:179455
- JNJ-8678
- RSV F Protein Inhibitor JNJ-53718678
- RSV Fusion Protein Inhibitor JNJ-53718678
- GTQTUABHRCWVLL-UHFFFAOYSA-N
- C21H20ClF3N4O3S
- RILEMATOVIR [WHO-DD]
- orb1707158
- SCHEMBL29413302
- SCHEMBL29903269
- GLXC-15178
- EX-A7782
- BDBM50542657
- MFCD30489307
- AKOS030527846
- AC-35754
- BJ178555
- MS-29303
- JNJ-53718678?
- DB-193106
- G15902
Look up RILEMATOVIR in the interactive SynDRA portal →